These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21125186)

  • 1. Anti-Jo-1 antisynthetase syndrome.
    Shinjo SK; Levy-Neto M
    Rev Bras Reumatol; 2010; 50(5):492-500. PubMed ID: 21125186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-synthetase syndrome: anti-PL-7, anti-PL-12 and anti-EJ].
    Souza FH; Cruellas MG; Levy-Neto M; Shinjo SK
    Rev Bras Reumatol; 2013 Aug; 53(4):352-7. PubMed ID: 24217667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult dermatomyositis: experience of a Brazilian tertiary care center.
    Souza FH; Barros TB; Levy-Neto M; Shinjo SK
    Rev Bras Reumatol; 2012 Dec; 52(6):897-902. PubMed ID: 23223700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
    Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
    Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
    Marie I; Hatron PY; Cherin P; Hachulla E; Diot E; Vittecoq O; Menard JF; Jouen F; Dominique S
    Arthritis Res Ther; 2013 Oct; 15(5):R149. PubMed ID: 24286268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.
    Stone KB; Oddis CV; Fertig N; Katsumata Y; Lucas M; Vogt M; Domsic R; Ascherman DP
    Arthritis Rheum; 2007 Sep; 56(9):3125-31. PubMed ID: 17763431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Jo-1-(antisynthetase-) syndrome--do autoantibodies improve classification of myositis?].
    Genth E; Mierau R
    Z Rheumatol; 1993; 52(5):259-63. PubMed ID: 8259716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type].
    Li S; Huang H; Song XY; Xu K; Wu CY; Wang Q; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Dec; 40(12):919-924. PubMed ID: 29224302
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA;
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term outcome of anti-Jo-1-positive inflammatory myopathies.
    Späth M; Schröder M; Schlotter-Weigel B; Walter MC; Hautmann H; Leinsinger G; Pongratz D; Müller-Felber W
    J Neurol; 2004 Jul; 251(7):859-64. PubMed ID: 15258790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-perifascicular atrophy in the healing phase of Jo-1 antisynthetase syndrome.
    Tateyama M; Shibuya S; Sato H; Fujihara K; Aoki M
    Neuromuscul Disord; 2016 Aug; 26(8):521-2. PubMed ID: 27321928
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease.
    Omotoso BA; Ogden MI; Balogun RA
    J Clin Apher; 2015 Dec; 30(6):375-9. PubMed ID: 25727180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody.
    Chmiel JF; Wessel HU; Targoff IN; Pachman LM
    J Rheumatol; 1995 Apr; 22(4):762-5. PubMed ID: 7791178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients.
    Lefèvre G; Meyer A; Launay D; Machelart I; DeBandt M; Michaud J; Tournadre A; Godmer P; Kahn JE; Behra-Marsac A; Timsit MA; Schleinitz N; Wendling D; Melac-Ducamp S; Boyer P; Peretz A; Lequerré T; Richez C; Stervinou-Wemeau L; Morell-Dubois S; Lambert M; Dubucquoi S; Wallaert B; Benveniste O; Flipo RM; Hatron PY; Sibilia J; Hachulla E; Hervier B;
    Rheumatology (Oxford); 2015 May; 54(5):927-32. PubMed ID: 25349440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum of anti-Jo-1-associated disease.
    Monti S; Montecucco C; Cavagna L
    Curr Opin Rheumatol; 2017 Nov; 29(6):612-617. PubMed ID: 28796005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.
    Ascherman DP
    Curr Rheumatol Rep; 2015 Sep; 17(9):56. PubMed ID: 26210509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.